Skip to main content

Table 1.

Summary of animal models for predicting vaccine effectiveness

Pathogen Key characteristics of animal challenge model
Immunological end points/assays Bridging animal data to human Animal studies predictive of vaccine protection against disease in humans
Pathogen challenge stock (human; animal prototype) Disease pattern similar to humans Correlate of protection identified Species-independent assay available
HPV Animal pathogen prototypes (bovine, dog) Partially Yes No Yes Yes
Anthraxa Human pathogen/validated Yes Yes Yes/validated Yes Yes
Ebola Human pathogen Yes Partially Not finalized;
not validated
No Partially
HIV Animal pathogen prototypes (SIV, SHIV) Partially No No No No

HPV, Human papillomavirus; SIV, simian immunodeficiency virus; SHIV, HIV strain.

aAnthrax vaccine was approved under the FDA “Animal Rule.”